Skip to main content

Elmind Capital, LP

13F filer · CIK 0002052213
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$398MU.S. long equity reported on 13F
Positions355 new · 4 closed
Net flow last quarter+$13MBuys minus sells
Top 10 positions weight66.6%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202635 positions
COGTCogent Biosciences, Inc.$45.3M11.38%0.68%Not reportedQ4 2025
SNDXSyndax Pharmaceuticals Inc$40.6M10.19%2.08%Not reportedQ4 2025
CLDXCelldex Therapeutics, Inc.$36.8M9.25%1.26%+14.5%Q4 2025
RLAYRelay Therapeutics, Inc.$27.4M6.89%0.67%+172.9%Q4 2025
PCVXVaxcyte, Inc.$26.3M6.61%0.31%+42.9%Q4 2025
VERAVera Therapeutics, Inc.$18.7M4.71%0.61%-9.5%Q4 2025
PHVSPharvaris N.V.$18.2M4.57%0.81%+10.5%Q4 2025
VRDNViridian Therapeutics, Inc.\DE$18.1M4.55%0.87%+84.1%Q4 2025
CTMXCytomX Therapeutics, Inc.$17.1M4.29%2.09%Not reportedQ4 2025
TVTXTravere Therapeutics, Inc.$16.6M4.18%0.31%+64.8%Q4 2025
LEGNLegend Biotech Corp$16.5M4.14%0.15%NewQ2 2026
BEAMBeam Therapeutics Inc.$16.3M4.11%0.46%Not reportedQ4 2025
CGEMCullinan Therapeutics, Inc.$12.6M3.16%1.07%+30.2%Q4 2025
NRIXNurix Therapeutics, Inc.$11.2M2.80%0.44%Not reportedQ4 2025
KRYSKrystal Biotech, Inc.$8.18M2.05%0.07%Not reportedQ4 2025
UTHRUNITED THERAPEUTICS Corp$8.13M2.04%0.04%Not reportedQ4 2025
SMMTSummit Therapeutics Inc.$7.19M1.81%0.06%NewQ2 2026
INSMINSMED Inc$6.93M1.74%0.03%NewQ2 2026
BCRXBiocryst Pharmaceuticals Inc$5.2M1.31%0.20%-48.0%Q4 2025
MBXMBX Biosciences, Inc.$5.02M1.26%0.19%-56.9%Q4 2025
PTGXProtagonist Therapeutics, Inc$4.66M1.17%0.06%Not reportedQ4 2025
URGNUroGen Pharma Ltd.$4.42M1.11%0.25%-45.5%Q4 2025
DBVTDBV Technologies S.A.$4.35M1.09%0.09%Not reportedQ1 2026
ALMSAlumis Inc.$3.66M0.92%Not reportedNot reportedQ1 2026
SUPNSupernus Pharmaceuticals, Inc.$3.26M0.82%0.12%+250.0%Q4 2025
BMRNBiomarin Pharmaceutical Inc$2.69M0.68%0.02%Not reportedQ4 2025
IMCRImmunocore Holdings plc$2.58M0.65%0.16%+39.3%Q4 2025
AMLXAmylyx Pharmaceuticals, Inc.$2.01M0.51%0.10%Not reportedQ4 2025
ALECAlector, Inc.$1.81M0.45%0.81%Not reportedQ4 2025
SEPNSepterna, Inc.$1.66M0.42%0.11%NewQ2 2026
DSGNDesign Therapeutics, Inc.$1.56M0.39%0.17%-48.1%Q4 2025
STROSutro Biopharma, Inc.$1.06M0.27%0.19%NewQ2 2026
WVEWave Life Sciences, Inc.$1.03M0.26%0.09%Not reportedQ4 2025
TYRATyra Biosciences, Inc.$639K0.16%0.03%-94.3%Q4 2025
ENGNenGene Therapeutics Inc.$363K0.09%0.31%Not reportedQ4 2025
Q1 2026Reported May 15, 202634 positions
COGTCogent Biosciences, Inc.$45.1M12.79%0.69%Not reportedQ4 2025
SNDXSyndax Pharmaceuticals Inc$43.3M12.30%2.10%Not reportedQ4 2025
CLDXCelldex Therapeutics, Inc.$27.4M7.79%1.30%Not reportedQ4 2025
CTMXCytomX Therapeutics, Inc.$21.4M6.07%2.67%+550.0%Q4 2025
KALVKalVista Pharmaceuticals, Inc.$20.6M5.84%1.99%+27.5%Q4 2025
CGONCG Oncology, Inc.$19.7M5.61%0.33%-40.8%Q4 2025
VERAVera Therapeutics, Inc.$19.4M5.51%0.75%Not reportedQ4 2025
PCVXVaxcyte, Inc.$18.4M5.22%0.22%+8.6%Q4 2025
PHVSPharvaris N.V.$13.4M3.82%0.73%Not reportedQ4 2025
TYRATyra Biosciences, Inc.$13.4M3.81%0.59%Not reportedQ4 2025
BEAMBeam Therapeutics Inc.$11.4M3.22%0.46%Not reportedQ4 2025
VRDNViridian Therapeutics, Inc.\DE$10.5M2.97%0.52%-37.7%Q4 2025
BCRXBiocryst Pharmaceuticals Inc$9.52M2.70%0.39%-53.5%Q4 2025
UTHRUNITED THERAPEUTICS Corp$8.89M2.53%0.04%+36.4%Q4 2025
CGEMCullinan Therapeutics, Inc.$7.53M2.14%0.86%+71.0%Q4 2025
NRIXNurix Therapeutics, Inc.$7.13M2.02%0.44%Not reportedQ4 2025
MBXMBX Biosciences, Inc.$6.3M1.79%0.44%Not reportedQ4 2025
KRYSKrystal Biotech, Inc.$5.68M1.61%0.07%Not reportedQ4 2025
DBVTDBV Technologies S.A.$5.54M1.57%0.09%NewQ1 2026
RLAYRelay Therapeutics, Inc.$5.34M1.52%0.28%Not reportedQ4 2025
TVTXTravere Therapeutics, Inc.$5.28M1.50%0.19%+61.5%Q4 2025
PTGXProtagonist Therapeutics, Inc$4.01M1.14%0.06%Not reportedQ4 2025
URGNUroGen Pharma Ltd.$3.96M1.12%0.45%+120.0%Q4 2025
ALMSAlumis Inc.$2.86M0.81%Not reportedNewQ1 2026
BMRNBiomarin Pharmaceutical Inc$2.66M0.75%0.02%-42.7%Q4 2025
DSGNDesign Therapeutics, Inc.$2.21M0.63%0.33%Not reportedQ4 2025
APLSApellis Pharmaceuticals, Inc.$2.01M0.57%0.04%Not reportedQ4 2025
ALECAlector, Inc.$1.94M0.55%0.81%Not reportedQ4 2025
IMCRImmunocore Holdings plc$1.76M0.50%0.11%Not reportedQ4 2025
AMLXAmylyx Pharmaceuticals, Inc.$1.56M0.44%0.10%Not reportedQ4 2025
ENGNenGene Therapeutics Inc.$1.43M0.41%0.31%Not reportedQ4 2025
WVEWave Life Sciences, Inc.$1.29M0.37%0.09%-60.3%Q4 2025
SUPNSupernus Pharmaceuticals, Inc.$1.03M0.29%0.03%Not reportedQ4 2025
EWTXEdgewise Therapeutics, Inc.$315K0.09%0.01%-66.7%Q4 2025
Q4 2025Reported Feb 17, 202634 positions
COGTCogent Biosciences, Inc.$41.6M12.27%0.73%NewQ4 2025
SNDXSyndax Pharmaceuticals Inc$39M11.50%2.12%NewQ4 2025
VRDNViridian Therapeutics, Inc.\DE$26.7M7.89%0.84%NewQ4 2025
VERAVera Therapeutics, Inc.$24.4M7.21%0.75%NewQ4 2025
CLDXCelldex Therapeutics, Inc.$23.5M6.93%1.30%NewQ4 2025
CGONCG Oncology, Inc.$20.4M6.03%0.61%NewQ4 2025
BCRXBiocryst Pharmaceuticals Inc$16.8M4.95%1.01%NewQ4 2025
PCVXVaxcyte, Inc.$13.4M3.97%0.22%NewQ4 2025
BEAMBeam Therapeutics Inc.$13.2M3.90%0.47%NewQ4 2025
PHVSPharvaris N.V.$13.2M3.90%0.73%NewQ4 2025
KALVKalVista Pharmaceuticals, Inc.$12.9M3.82%1.57%NewQ4 2025
DVAXDynavax Technologies Corp$10.5M3.09%0.58%NewQ4 2025
TYRATyra Biosciences, Inc.$9.2M2.72%0.65%NewQ4 2025
NRIXNurix Therapeutics, Inc.$8.73M2.58%0.45%NewQ4 2025
WVEWave Life Sciences, Inc.$7.61M2.25%0.24%NewQ4 2025
MBXMBX Biosciences, Inc.$6.65M1.96%0.47%NewQ4 2025
KRYSKrystal Biotech, Inc.$5.42M1.60%0.08%NewQ4 2025
UTHRUNITED THERAPEUTICS Corp$5.36M1.58%0.03%NewQ4 2025
BMRNBiomarin Pharmaceutical Inc$4.87M1.44%0.04%NewQ4 2025
RLAYRelay Therapeutics, Inc.$4.54M1.34%0.31%NewQ4 2025
TVTXTravere Therapeutics, Inc.$4.2M1.24%0.12%NewQ4 2025
PTGXProtagonist Therapeutics, Inc$3.32M0.98%0.06%NewQ4 2025
CGEMCullinan Therapeutics, Inc.$3.21M0.95%0.51%NewQ4 2025
LQDALiquidia Corp$3.1M0.92%0.10%NewQ4 2025
CTMXCytomX Therapeutics, Inc.$2.98M0.88%0.41%NewQ4 2025
URGNUroGen Pharma Ltd.$2.34M0.69%0.21%NewQ4 2025
IMCRImmunocore Holdings plc$2.02M0.60%0.11%NewQ4 2025
DSGNDesign Therapeutics, Inc.$1.95M0.58%0.34%NewQ4 2025
ENGNenGene Therapeutics Inc.$1.9M0.56%0.31%NewQ4 2025
ALECAlector, Inc.$1.4M0.41%0.82%NewQ4 2025
AMLXAmylyx Pharmaceuticals, Inc.$1.35M0.40%0.10%NewQ4 2025
APLSApellis Pharmaceuticals, Inc.$1.26M0.37%0.04%NewQ4 2025
SUPNSupernus Pharmaceuticals, Inc.$994K0.29%0.03%NewQ4 2025
EWTXEdgewise Therapeutics, Inc.$744K0.22%0.03%NewQ4 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.